Our latest AI+QQ prediction shows actual CNS ion channel potentiation via in vitro functional assay, setting up a lead candidate for further optimization.
More from our wet lab work: Prediction from our AI+QQ in silico process showing actual in vitro inhibition effect on another specific human protease (two candidates in diagram)
Latest update: Prediction from our AI+QQ in silico process showing actual in vitro inhibition effect on another specific human protease. Exciting to see our predictions in-silico validated in the wet labs.
The wet lab streak continues: Prediction from our AI+QQ in silico process showing actual in vitro inhibition effect on another specific human protease.
Latest from the wet labs. Prediction from our AI+QQ in-silico process showing actual in vitro inhibition effect on CNS ion channels (our foray into CNS indications).
More progress from wet labs. Prediction from our AI+QQ in-silico process showing actual in vitro potentiation effect on cardiac ion channel (our first foray into a cardiac indication). This is #2 of 2 potentiation candidates that showed effect.
Next off the wet lab – Prediction from our AI+QQ in-silico predicted process showing actual in vitro potentiation effect on cardiac ion channel (our first foray into a cardiac indication). This is #1 of 2 potentiation candidates that showed effect.
Feeling like we are on a streak now. From the wet labs – Prediction from our AI+QQ in silico process showing actual in vitro potentiation effect on specific human protease.
Our latest progress from the wet labs. Prediction from our AI+QQ in-silico predicted process showing actual in vitro potentiation effect against specific human apoptotic protease.
More results from the wet labs -- here our AI+QQ in-silico process is predicting the actual in vitro effect potentiation against an ion channel (our first foray into a CNS indication).
Join us in revolutionizing the field of drug discovery and improving the lives of patients worldwide. If you are interested in partnering with ARIScience please contact us today to discuss collaboration opportunities.
